Inhibition of the endogenous CSE/H2S system contributes to hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells
Authors:
- 3 April 2014
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 9 (6) , 2467-2472
Abstract
Mesenchymal stem cells (MSCs) have great potential for repair following acute myocardial infarction. However, a major challenge to MSC therapy is that transplanted cells undergo apoptosis. Hydrogen sulfide (H2S) has recently been proposed as an endogenous mediator of cell apoptosis in various systems. The aim of the present study was to investigate the role of endogenous H2S in hypoxia and serum deprivation (hypoxia/SD)-induced apoptosis in MSCs. The present study demonstrated that exposure of MSCs to hypoxia/SD caused a significant decrease in H2S generation and resulted in marked cell apoptosis. Furthermore, under basal conditions, MSCs expressed cystathionine γ-lyase (CSE) and synthesized H2S, whereas CSE expression and activity was inhibited by hypoxia/SD treatment. Overexpression of CSE not only markedly prevented hypoxia/SD-induced decreases in endogenous H2S generation but also protected MSCs from apoptosis, while inhibition of CSE by its potent inhibitors significantly deteriorated the effect of hypoxia/SD in MSCs. These data indicate that the H2S generation pathway exists in MSCs and the inhibition of the endogenous CSE/H2S system contributes to hypoxia/SD-induced apoptosis in MSCs. Our findings suggest that modulation of the CSE/H2S system is a potential therapeutic avenue for promoting the viability of transplanted MSCs.Keywords
This publication has 32 references indexed in Scilit:
- Hydrogen sulfide is an endogenous stimulator of angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- Mesenchymal stem cells and cardiac repairJournal of Cellular and Molecular Medicine, 2008
- Systems approaches to preventing transplanted cell death in cardiac repairJournal of Molecular and Cellular Cardiology, 2008
- Intraoperative Cell Transplantation for Congestive Heart Failure: Experience in ChinaSeminars in Thoracic and Cardiovascular Surgery, 2008
- Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarctionJournal of Molecular and Cellular Cardiology, 2006
- Stem Cells as a Source of Regenerative CardiomyocytesCirculation Research, 2006
- Hypoxia and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem CellsStem Cells, 2005
- Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat MyocardiumCirculation, 2005
- Stem-cell therapy for myocardial diseasesThe Lancet, 2004
- Lifetime Risk for Developing Congestive Heart FailureCirculation, 2002